Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome: a Multicenter, Randomized, Doubleblind, Placebo-controlled Study

NCT05411900 is registered in ClinicalTrials.gov with Francesco Bono as lead sponsor.

NCT NCT05411900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05411900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BotulInum Toxin Type A for Peripheral Neuropathic Pain in subjEcts With Carpal Tunnel Syndrome: a Multicenter, Randomized, Doubleblind, Placebo-controlled Study
Lead sponsor
Francesco Bono
Phase
Phase 2
Overall status
Unknown status
Start date
May 25, 2022
Completion date
December 31, 2023
Enrollment
164 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carpal tunnel syndrome, drug use, neurogenic inflammation, neuropathic pain, pain